Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Methylation and polygenic risk scores capture different features of systemic lupus erythematosus.

Rheumatology (Oxford, England)·2026

Same author

Plasmacytoid dendritic cells in systemic and cutaneous lupus erythematosus: an evolving understanding.

Frontiers in immunology·2026

Same author

Comparison of BAFF and type I IFN activity in blood and placenta in SLE and healthy pregnancies.

Lupus science & medicine·2026

Same author

Single-cell RNA-seq reveals a persistent interferon signature in immune cells from systemic lupus erythematosus patients with high versus low polygenic risk scores despite antimalarial treatment.

Journal of autoimmunity·2026

Same author

Systemic lupus erythematosus: from an adverse event of interferon administration to a disease with new treatment options.

Upsala journal of medical sciences·2026

Same author

Proteomic analysis reveals angiogenesis-related plasma proteins associated with pre-eclampsia in SLE.

Lupus science & medicine·2025

Search research articles

Related Experiment Video

Updated: May 16, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Type I interferons in Sjögren's syndrome.

Yihong Yao¹, Zheng Liu, Bahija Jallal

¹Translational Sciences, MedImmune, LLC, USA. YaoY@medimmune.com

Autoimmunity Reviews

|December 4, 2012

Summary

The type I interferon system is crucial in Sjögren's syndrome pathogenesis, with over-expressed genes linked to disease activity. Targeting this system offers potential therapeutic benefits for patients.

More Related Videos

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Published on: March 1, 2024

Related Experiment Videos

Last Updated: May 16, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Published on: March 1, 2024

Area of Science:

Immunology
Autoimmune Diseases
Molecular Biology

Background:

Sjögren's syndrome is a chronic autoimmune disorder affecting salivary and lacrimal glands, causing dry eyes and mouth.
Pathogenesis involves genetic, infectious, and hormonal factors, with recent focus on the type I interferon (IFN) system.

Purpose of the Study:

To review the role of the type I interferon system in Sjögren's syndrome.
To explore mechanisms of type I IFN activation and its implications for disease pathogenesis.

Main Methods:

Review of recent studies on type I IFN gene expression in Sjögren's syndrome patients.
Analysis of correlations between type I IFN-inducible genes and disease markers like anti-Ro/La antibodies.
Examination of plasmacytoid dendritic cell (pDC) involvement and genetic risk factors.

Main Results:

Marked over-expression of type I IFN-inducible genes is observed in Sjögren's syndrome patients.
Type I IFN gene expression correlates with autoantibody titers and disease activity.
Activated pDCs are present in salivary glands, and genetic variations in IFN pathways increase Sjögren's syndrome risk.

Conclusions:

The type I interferon system plays a significant role in Sjögren's syndrome pathogenesis.
Therapeutic strategies targeting the type I IFN pathway may benefit patients with elevated IFN status.
Further clinical evaluation of type I IFN-targeted therapies is warranted.